Search for Clinical Trial Results
Neurofibroma, Plexiform - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Study to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Subjects With Cancers Harboring V600 Mutations Condition: Cancer Date: 2014-04-24 Interventions:
|
Completed |
Study Name: PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma Condition:
|
Recruiting |
Study Name: AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors Condition:
Interventions: Drug: AZD6244 AZD6244 orally every 12 hours on continuous daily schedule for cycles of 28 days until una |
Active, not recruiting |
Study Name: Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas Condition:
Date: 2010-06-08 Interventions: Drug: Gleevec Gleevec will be dosed orally with a starting dose of 100 mg twice daily for patients with |
Completed |
Study Name: Phase II Study of Gleevec/Imatinib Mesylate (STI-571, NCS 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas Condition: Neurofibromatosis Date: 2012-08-22 Interventions: Drug: Gleevec Gleevec® will be dosed orally 440 mg/m^2/day (max 800 mg/day) for pediatric subjects |